Literature DB >> 1480878

Methods for the analysis of informatively censored longitudinal data.

M D Schluchter1.   

Abstract

This paper describes the problem of informative censoring in longitudinal studies where the primary outcome is rate of change in a continuous variable. Standard approaches based on the linear random effects model are valid only when the data are missing in a non-ignorable fashion. Informative censoring, which is a special type of non-ignorably missing data, occurs when the probability of early termination is related to an individual subject's true rate of change. When present, informative censoring causes bias in standard likelihood-based analyses, as well as in weighted averages of individual least-squares slopes. This paper reviews several methods proposed by others for analysis of informatively censored longitudinal data, and outlines a new approach based on a log-normal survival model. Maximum likelihood estimates may be obtained via the EM algorithm. Advantages of this approach are that it allows general unbalanced data caused by staggered entry and unequally-timed visits, it utilizes all available data, including data from patients with only a single measurement, and it provides a unified method for estimating all model parameters. Issues related to study design when informative censoring may occur are also discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1480878     DOI: 10.1002/sim.4780111408

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  47 in total

1.  Random Regression Models Based On The Skew Elliptically Contoured Distribution Assumptions With Applications To Longitudinal Data.

Authors:  Shimin Zheng; Uma Rao; Alfred A Bartolucci; Karan P Singh
Journal:  J Appl Probab Stat       Date:  2009-05

2.  The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiers.

Authors:  J Bacik; M Mazumdar; B A Murphy; D L Fairclough; S Eremenco; T Mariani; R J Motzer; D Cella
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

3.  Jointly modeling longitudinal proportional data and survival times with an application to the quality of life data in a breast cancer trial.

Authors:  Hui Song; Yingwei Peng; Dongsheng Tu
Journal:  Lifetime Data Anal       Date:  2015-09-24       Impact factor: 1.588

4.  Slope Estimation of Covariates that Influence Renal Outcome following Renal Transplant Adjusting for Informative Right Censoring.

Authors:  Miran A Jaffa; Ayad A Jaffa; Stuart R Lipsitz
Journal:  J Appl Stat       Date:  2012       Impact factor: 1.404

5.  Mixtures of varying coefficient models for longitudinal data with discrete or continuous nonignorable dropout.

Authors:  Joseph W Hogan; Xihong Lin; Benjamin Herman
Journal:  Biometrics       Date:  2004-12       Impact factor: 2.571

6.  An approach to joint analysis of longitudinal measurements and competing risks failure time data.

Authors:  Robert M Elashoff; Gang Li; Ning Li
Journal:  Stat Med       Date:  2007-06-30       Impact factor: 2.373

7.  Longitudinal Analysis when the Experimenter does not Determine when Treatment Ends: What is Dose-Response?

Authors:  Daniel J Feaster; Frederick L Newman; Christopher Rice
Journal:  Clin Psychol Psychother       Date:  2003

8.  A corrected pseudo-score approach for additive hazards model with longitudinal covariates measured with error.

Authors:  Xiao Song; Yijian Huang
Journal:  Lifetime Data Anal       Date:  2006-03       Impact factor: 1.588

9.  Nonparametric multistate representations of survival and longitudinal data with measurement error.

Authors:  Bo Hu; Liang Li; Xiaofeng Wang; Tom Greene
Journal:  Stat Med       Date:  2012-04-26       Impact factor: 2.373

10.  Joint Modeling of Repeated Measures and Competing Failure Events In a Study of Chronic Kidney Disease.

Authors:  Wei Yang; Dawei Xie; Qiang Pan; Harold I Feldman; Wensheng Guo
Journal:  Stat Biosci       Date:  2016-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.